Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer

References

• Li YJ, Wu JY, Wang JM, et al. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer. J Control Release. 2020;320:1–13. doi: 10.1016/j.jconrel.2020.01.041.
   PubMed Web of Science ®Google Scholar
• Haeberle L, Esposito I. Pathology of pancreatic cancer. Transl Gastroenterol Hepatol. 2019;4:50. doi: 10.21037/tgh.2019.06.02.
   PubMed Web of Science ®Google Scholar
• Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10–27. doi: 10.14740/wjon1166.
   PubMedGoogle Scholar
• Goggins M, Overbeek KA, Brand R, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69(1):7–17. doi: 10.1136/gutjnl-2019-319352.
   PubMed Web of Science ®Google Scholar
• Luchini C, Brosens LAA, Wood LD, et al. Comprehensive characterization of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications. Gut. 2021;70(1):148–156. doi: 10.1136/gutjnl-2020-320726.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller, KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–451. doi: 10.3322/caac.21583.
   PubMed Web of Science ®Google Scholar
• Deberardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200. doi: 10.1126/sciadv.1600200.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Halbrook CJ, Lyssiotis CA. Employing metabolism to improve the diagnosis and treatment of pancreatic cancer. Cancer Cell. 2017;31(1):5–19. doi: 10.1016/j.ccell.2016.12.006.
   PubMed Web of Science ®Google Scholar
• Karasinska JM, Topham JT, Kalloger SE, et al. Altered gene expression along the glycolysis-cholesterol synthesis axis is associated with outcome in pancreatic cancer. Clin Cancer Res. 2020;26(1):135–146. doi: 10.1158/1078-0432.CCR-19-1543.
   PubMed Web of Science ®Google Scholar
• Zhou D, Mu D, Cheng M, et al. Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer. Acta Cir Bras. 2020;35(5):e202000508. doi: 10.1590/s0102-865020200050000008.
   PubMed Web of Science ®Google Scholar
• Gabitova-Cornell L, Surumbayeva A, Peri S, et al. Cholesterol pathway inhibition induces TGF-beta signaling to promote basal differentiation in pancreatic cancer. Cancer Cell. 2020;38(4):567–583 e11. doi: 10.1016/j.ccell.2020.08.015.
   PubMed Web of Science ®Google Scholar
• Lee JH, Cho YR, Kim JH, et al. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism. Exp Mol Med. 2019;51(11):1–11. doi: 10.1038/s12276-019-0350-z.
   Google Scholar
• Hui S, Ghergurovich JM, Morscher RJ, et al. 2017. Glucose feeds the TCA cycle via circulating lactate. Nature, 551(7678), 115–118. doi: 10.1038/nature24057.
   PubMed Web of Science ®Google Scholar
• Recouvreux MV, Moldenhauer MR, Galenkamp KMO, et al. Glutamine depletion regulates slug to promote EMT and metastasis in pancreatic cancer. J Exp Med. 2020;217(9):e20200388. doi: 10.1084/jem.20200388.
   PubMed Web of Science ®Google Scholar
• Son J, Lyssiotis CA, Ying H, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496(7443):101–105. doi: 10.1038/nature12040.
   PubMed Web of Science ®Google Scholar
• Peng X, Chen Z, Farshidfar F, et al. Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers. Cell Rep. 2018;23(1):255–269 e4. doi: 10.1016/j.celrep.2018.03.077.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi: 10.1089/omi.2011.0118.
   PubMed Web of Science ®Google Scholar
• Ito K, Murphy D. Application of ggplot2 to pharmacometric graphics. CPT Pharmacometrics Syst Pharmacol. 2013;2(10):e79. doi: 10.1038/psp.2013.56.
   PubMedGoogle Scholar
• Zhao X, Zeng Z, Chen A, et al. Comprehensive strategy to construct in-house database for accurate and batch identification of small molecular metabolites. Anal Chem. 2018;90(12):7635–7643. doi: 10.1021/acs.analchem.8b01482.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang X, Zhou Y, et al. Protective effect of metformin on BPA-induced liver toxicity in rats through upregulation of cystathionine beta synthase and cystathionine gamma lyase expression. Sci Total Environ. 2021;750:141685. doi: 10.1016/j.scitotenv.2020.141685.
   PubMed Web of Science ®Google Scholar
• Guo X, Long P, Meng Q, et al. An emerging strategy for evaluating the grades of Keemun black tea by combinatory liquid chromatography-Orbitrap mass spectrometry-­based untargeted metabolomics and inhibition effects on alpha-glucosidase and alpha-amylase. Food Chem. 2018;246:74–81. doi: 10.1016/j.foodchem.2017.10.148.
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47. doi: 10.1016/j.cmet.2015.12.006.
   PubMed Web of Science ®Google Scholar
• Svensson RU, Shaw RJ. Cancer metabolism: tumour friend or foe. Nature. 2012;485(7400):590–591. doi: 10.1038/485590a.
   PubMed Web of Science ®Google Scholar
• Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152. doi: 10.1186/1476-4598-12-152.
   PubMed Web of Science ®Google Scholar
• Yue M, Jiang J, Gao P, et al. Oncogenic MYC activates a feedforward regulatory loop promoting essential amino acid metabolism and tumorigenesis. Cell Rep. 2017;21(13):3819–3832. doi: 10.1016/j.celrep.2017.12.002.
   PubMed Web of Science ®Google Scholar
• Biancur DE, Kimmelman AC. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance. Biochim Biophys Acta Rev Cancer. 2018;1870(1):67–75. doi: 10.1016/j.bbcan.2018.04.011.
   PubMed Web of Science ®Google Scholar
• Qin C, Yang G, Yang J, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer. 2020;19(1):50. doi: 10.1186/s12943-020-01169-7.
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891–899. doi: 10.1038/nrc1478.
   PubMed Web of Science ®Google Scholar
• An Y, Cai H, Yang Y, et al. Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis. Cancer Sci. 2018;109(9):2811–2821. doi: 10.1111/cas.13733.
   PubMed Web of Science ®Google Scholar
• Zhang G, He P, Tan H, et al. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Cancer Res. 2013;19(18):4983–4993. doi: 10.1158/1078-0432.CCR-13-0209.
   PubMed Web of Science ®Google Scholar
• Bott AJ, Shen J, Tonelli C, et al. Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism. Cell Rep. 2019;29(5):1287–1298 e6. doi: 10.1016/j.celrep.2019.09.056.
   PubMed Web of Science ®Google Scholar
• Sun H, Ma H, Hong G, et al. Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981–2010. Sci Rep. 2014;4:6747. doi: 10.1038/srep06747.
   PubMed Web of Science ®Google Scholar
• Vaccaro V, Sperduti I, Milella M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;365(8):768–769; author reply 769. doi: 10.1056/NEJMc1107627.
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691–1703. doi: 10.1056/NEJMoa1304369.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang N, Zhou Y, et al. Oridonin induces ferroptosis by inhibiting gamma-glutamyl cycle in TE1 cells. Phytother Res. 2021;35(1):494–503. doi: 10.1002/ptr.6829.
   PubMed Web of Science ®Google Scholar
• Liss DB, Paden MS, Schwarz ES, et al. What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure? Clin Toxicol. 2013;51(9):817–827. doi: 10.3109/15563650.2013.844822.
   Web of Science ®Google Scholar
• Priolo C, Khabibullin D, Reznik E, et al. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma. Proc Natl Acad Sci USA. 2018;115(27):E6274–E6282. doi: 10.1073/pnas.1710849115.
   PubMed Web of Science ®Google Scholar
• Badgley MA, Kremer DM, Maurer HC, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368(6486):85–89. doi: 10.1126/science.aaw9872.
   PubMed Web of Science ®Google Scholar
• Park J, Shin Y, Kim TH, et al. Plasma metabolites as possible biomarkers for diagnosis of breast cancer. PLoS One. 2019;14(12):e0225129. doi: 10.1371/journal.pone.0225129.
   PubMed Web of Science ®Google Scholar
• Shi J, Yi Z, Jin L, et al. Cyst fluid metabolites distinguish malignant from benign pancreatic cysts. Neoplasia. 2021;23(11):1078–1088. doi: 10.1016/j.neo.2021.09.004.
   PubMed Web of Science ®Google Scholar
• Metges CC, Yu YM, Cai W, et al. Plasma L-5-oxoproline carbon and nitrogen kinetics in healthy young adults. J Nutr. 1999;129(11):1998–2004. doi: 10.1093/jn/129.11.1998.
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Peiris-Pages M, Pestell RG, et al. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14(1):11–31. doi: 10.1038/nrclinonc.2016.60.
   PubMed Web of Science ®Google Scholar
• Rajeshkumar NV, Yabuuchi S, Pai SG, et al. Treatment of pancreatic cancer patient-derived xenograft panel with metabolic inhibitors reveals efficacy of phenformin. Clin Cancer Res. 2017;23(18):5639–5647. doi: 10.1158/1078-0432.CCR-17-1115.
   PubMed Web of Science ®Google Scholar
• Linton SS, Abraham T, Liao J, et al. Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. PLoS One. 2018;13(11):e0206759. doi: 10.1371/journal.pone.0206759.
   PubMed Web of Science ®Google Scholar
• Janakiram NB, Mohammed A, Bryant T, et al. Loss of natural killer T cells promotes pancreatic cancer in LSL-Kras(G12D/+) mice. Immunology. 2017;152(1):36–51. doi: 10.1111/imm.12746.
   PubMed Web of Science ®Google Scholar
• Engle DD, Tiriac H, Rivera KD, et al. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science. 2019;364(6446):1156–1162. doi: 10.1126/science.aaw3145.
   PubMed Web of Science ®Google Scholar
• Comba A, Almada LL, Tolosa EJ, et al. Nuclear factor of activated T cells-dependent down-regulation of the transcription factor glioma-associated protein 1 (GLI1) underlies the growth inhibitory properties of arachidonic acid. J Biol Chem. 2016;291(4):1933–1947. doi: 10.1074/jbc.M115.691972.
   PubMed Web of Science ®Google Scholar
• Hughes-Fulford M, Li CF, Boonyaratanakornkit J, et al. Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer. Cancer Res. 2006;66(3):1427–1433. doi: 10.1158/0008-5472.CAN-05-0914.
   PubMed Web of Science ®Google Scholar
• Monjazeb AM, High KP, Connoy A, et al. Arachidonic acid-induced gene expression in Colon cancer cells. Carcinogenesis. 2006;27(10):1950–1960. doi: 10.1093/carcin/bgl023.
   PubMed Web of Science ®Google Scholar
• Brunton H, Caligiuri G, Cunningham R, et al. HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer. Cell Rep. 2020;31(6):107625. doi: 10.1016/j.celrep.2020.107625.
   PubMed Web of Science ®Google Scholar